Johnson & Johnson Expands Massive Recall

335

Johnson & Johnson is expanding a recall from January to include certain over-the-counter drugs that have garnered complaints of nausea and sickness due to an odor they possess, according to the Associated Press.

McNeil Consumer Healthcare, a subsidiary of Johnson & Johnson, announced June 16 that they had inadvertently excluded one lot of Extra Strength Tylenol Rapid Release Gels and four lots of Benadryl Allergy Ultratab Tablets from their initial Jan. 15 recall. The products were distributed to the U.S., Tobago, and Bermuda.

The company has been the target of congressional investigations and citations by the Food and Drug Administration for its numerous recalls over the course of eight months.

“McNeil should have acted faster,” Deborah Autor, the director of the FDA’s Office of Compliance of the Center for Drug Evaluation and Research told the AP. “When something smells bad, literally or figuratively, companies must aggressively investigate and take all necessary action to solve the problem.”

The FDA said McNeil was aware of the problem in 2008, but only implemented a limited investigation.

Other recalled products from the company include Tylenol Arthritis Pain Caplets, Zyrtec Itchy Eye Drops and Children’s Zyrtec products, among others.

The odor from the recalled medicine is derived from trace amounts of tribomanisole, or TBA, a chemical applied to the wooden pallets that are used to store and transport the medicine’s packaging materials.

According to CNN.com, the recalls have affected the availability of the drugs. Bonnie Jacobs told CNNMoney that “the pace of restocking is accelerating” following the January recall and the company expects to be “at close to normal levels of production towards the second quarter.”

Consumers who have purchased the products are urged to immediately contact McNeil Consumer Healthcare for a replacement or refund.

For more information and a full listing of recalled McNeil products, visit: www.mcneilproductrecall.com.